Previous research has primarily concentrated on machine learning (ML)-based classification of dementia stages by integrating CSF biomarkers with various other parameters, rather than relying on CSF biomarkers alone.15 These studies have explored the synergistic potential of combining CSF biomarkers such as amyloid-beta and tau proteins with clinical assessments, cognitive scores, genetic factors, and imaging data. Here, MAPT is linked to dementia.